SOW
AXSM icon

State of Wyoming’s Axsome Therapeutics AXSM Stock Holding History

State of Wyoming’s Portfolio AXSM Stock Details AXSM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$184K Buy
+752
New +$163K 0.02% 1070
2025
Q3 		– Sell
-146
Closed -$15.2K – 1843
2025
Q2 		$15.2K Buy
+146
New +$15.5K ﹤0.01% 1737
2022
Q3 		– Sell
-52
Closed -$2K – 1545
2022
Q2 		$2K Buy
52
+12
+30% +$380 ﹤0.01% 1772
2022
Q1 		$2K Buy
40
+11
+38% +$341 ﹤0.01% 1701
2021
Q4 		$1K Sell
29
-2
-6% -$74 ﹤0.01% 1797
2021
Q3 		$1K Sell
31
-22
-42% -$857 ﹤0.01% 1170
2021
Q2 		$4K Buy
53
+22
+71% +$1.32K ﹤0.01% 1084
2021
Q1 		$2K Buy
+31
New +$2.18K ﹤0.01% 466

Other funds holding AXSM

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
DTC
Deep Track Capital Greenwich, Connecticut $6.87B AUM 205.24% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return

State of Wyoming's AXSM Position: Q2 2026 in Review

State of Wyoming opened a new position in Axsome Therapeutics (AXSM) in Q2 2026: 752 shares worth $184K. The stake represents 0.02% of the portfolio and ranks #1070 among its holdings. This is a return to the name: State of Wyoming previously reported a position in AXSM as recently as Q2 2025.

State of Wyoming first reported a position in AXSM in Q1 2021 and has held it in 8 quarters since. 506 funds tracked by Wall St. Rank hold AXSM as of Q2 2026.

  • State of Wyoming held 752 shares of Axsome Therapeutics worth $184K as of Q2 2026.
  • Axsome Therapeutics was a new State of Wyoming position in Q2 2026.
  • Axsome Therapeutics made up 0.02% of State of Wyoming's portfolio in Q2 2026, its #1070 holding.
  • State of Wyoming first reported a position in Axsome Therapeutics in Q1 2021 and has held it in 8 quarters since.
  • 506 funds tracked by Wall St. Rank held Axsome Therapeutics as of Q2 2026.

Based on State of Wyoming's 13F filing for Q2 2026, filed 6 Aug 2026.